Astellas Pharma Inc.

ALPMF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$1,940$215,399$188,372$179,865
Short-Term Investments$0$0$29,941$0
Receivables$4,843$668,852$632,525$644,633
Inventory$2,096$305,692$297,261$287,343
Other Curr. Assets$374$103,388$53,250$92,072
Total Curr. Assets$9,253$1,293,331$1,201,349$1,203,913
Property Plant & Equip (Net)$2,259$323,368$328,921$332,724
Goodwill$2,790$402,491$415,207$432,795
Intangibles$7,040$1,036,699$1,123,714$1,211,344
Long-Term Investments$1,005$16,781$172,239$19,148
Tax Assets$776$0$98,113$0
Other NC Assets$200$263,163$1$251,706
Total NC Assets$14,071$2,042,502$2,138,195$2,247,717
Other Assets$0$0$0$0
Total Assets$23,324$3,335,833$3,339,544$3,451,630
Liabilities
Payables$1,140$165,891$187,840$204,305
Short-Term Debt$2,843$331,414$266,533$329,853
Tax Payable$0$0$34,549$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,977$610,632$572,688$618,399
Total Curr. Liab.$8,960$1,107,937$1,061,610$1,152,557
LT Debt$2,163$558,076$564,893$585,511
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$38$0$5,353$0
Other NC Liab.$1,263$188,028$194,433$219,753
Total NC Liab.$3,464$746,104$764,679$805,264
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$12,424$1,854,041$1,826,289$1,957,821
Equity
Pref Stock$0$0$0$0
Common Stock$696$103,001$103,001$103,001
Retained Earnings$5,563$742,235$740,939$654,059
AOCI$3,636$488,935$521,580$590,219
Other Equity$1,004$147,621$147,735$146,530
Total Equity$10,900$1,481,792$1,513,255$1,493,809
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$23,324$3,335,833$3,339,544$3,451,630
Net Debt$3,066$674,091$643,054$735,499